Aim: In our study, we investigated the efficiency of the prognostic nutritional index (PNI) score and the CRP, age, platelet count, albumin level (CAPA) score predicting mortality and intensive car... Lay abstract The COVID-19 pandemic is a global health problem that affects all societies. In order to deal with this urgent situation, the rapid spread of the disease in outbreaks requires categori...
Background and aims: Favipiravir is a ribonucleic acid (RNA)-dependent RNA polymerase (RdRP) inhibitor antiviral agent used in the treatment of coronavirus disease-2019 (COVID-19). In this study, we investigated the changes in serum transaminase levels of patients and the relationship between serum transaminase elevation with mortality in patients who were hospitalized with the diagnosis of COVID-19 and received favipiravir treatment. Materials and methods: 454 patients who received favipiravir and 113 patients who did not receive favipiravir were evaluated. Serum transaminase levels of the patients were compared at baseline and after five days of treatment, and the relationship between serum transaminase elevation and mortality was investigated. Results: No significant aspartate aminotransferase (AST) or alanine aminotransferase (ALT) elevation was detected due to favipiravir treatment. AST elevation was found, respectively, as 133 (29.3%), 32 (28.3%) (p=0.100), ALT elevation as 112 (24.7%), 35 (29.3%) (p=0.100) in the groups receiving and not receiving favipiravir. High AST level was found as a risk factor for mortality in all patient groups (p=0.008). Conclusions: There was no statistically significant elevation in serum transaminase levels due to favipiravir use in patients hospitalized for COVID-19. A high level of AST is a significant risk factor to show mortality and intensive care unit (ICU) admission in patients with COVID-19.
5 September 2021 in Journal of Health Sciences and Medicine
Introduction: The COVID-19 pandemic has shown that patients should be categorized according to their risk group, patient follow-up and the use of health resources should be arranged according to this categorization. Therefore, practical and inexpensive biomarkers are needed. In this study, the relationship between neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), mean platelet volume (MPV) and red blood cell distribution width (RDW) levels, which can be easily calculated by complete blood count, with mortality and intensive care unit (ICU) admission in COVID-19 disease was evaluated. Materials and Methods: 748 inpatients with positive COVID-19 PCR test were evaluated retrospectively. The NLR, PLR, MPV and RDW levels calculated from the complete blood count parameters of the patients at hospital admissions and their relationship with the mortality and the ICU admission in COVID-19 disease were evaluated. Results: In terms of mortality, a statistically significant difference was found between RDW levels in the evaluation performed in the patient groups who survived and died (p: 0.014). No statistically significant difference was found in NLR, PLR and MPV levels. In the evaluation made between ICU (+) and ICU (-) groups, a statistically significant difference was found in RDW and NLR levels (p: 0.042, p: 0.01, respectively). There was no statistically significant difference between PLR and MPV levels for ICU admission. Conclusion: RDW level was found to be associated with COVID-19 related mortality and ICU admission.
Background and Objectives: Determination of disease activity is important for appropriate treatment selection and clinical follow-up in ulcerative colitis (UC). Colonoscopic examination is the gold standard in the evaluation of disease activity in current clinical practice. However, colonoscopic procedures are invasive, expensive, and not comfortable for the patients; also, possible complications that may develop during the procedure have led clinicians to seek practical, economical, and reproducible new biomarkers that can be used in the clinical follow-up of UC patients. In our study, we aimed to analyze the relationship between the nutritional markers, such as prognostic nutritional index (PNI) and controlling nutritional status score (CONUT), with clinical and endoscopic activities of the disease in ulcerative colitis disease. Materials and Methods: The study included 196 patients who were followed up with the diagnosis of ulcerative colitis in the Internal Medicine Clinic and Gastroenterology Outpatient Clinic of our hospital. Demographic data, laboratory parameters, and endoscopy reports of the patients were reviewed retrospectively. Patients were divided into two groups: remission-mild disease and moderate-severe disease in terms of clinical activity, and endoscopic remission and active disease in terms of endoscopic activity. The relationship between the PNI and CONUT scores calculated from the results of the examinations at the hospital admissions with the Mayo score and Rachmilewitz endoscopic activity index scores stated in the endoscopy reports was analyzed. Results: In our study, 78 (39.8%) cases were female and 118 (60.2%) were male. The mean age was 40.28 ± 13.74 years. According to clinical activity, 90 (45.9%) of the cases had remission-mild disease, and 106 (54.1%) had moderate-to-severe disease. According to endoscopic activity, endoscopic remission was observed in 66 (33.7%) cases, and active disease was observed in 130 (66.3%) cases. PNI score was detected to be statistically significantly lower in the moderate-to-severe clinical activity group and endoscopically active patient group compared to the other groups, while the CONUT score was detected to be statistically significantly higher (p < 0.001; p < 0.001). Conclusions: PNI and CONUT scores are not only effective predictors of clinical and endoscopic disease activity in UC but also emphasize the critical role of nutritional assessment in the holistic management of inflammatory bowel disease. These findings suggest that integrating routine nutritional screening into gastroenterology practice can provide dual benefits: serving as a non-invasive biomarker for mucosal inflammation and identifying patients who may require early nutritional intervention to improve clinical outcomes.
Giriş ve Amaç: Perkütan endoskopik gastrostomi uygulaması uzun yıllardır enteral nutrisyon için kullanılan bir yöntemdir. Perkütan endoskopik gastrostomi kateteri kendiliğinden çıktığı veya hasta tarafından çıkarıldığı durumlarda aynı yol üzerinden uygulanan Foley kateter ile de enteral nutrisyonun devamı sağlanabilmektedir. Biz de perkütan endoskopik gastrostomi kateteri yerine Foley kateter kullanımını retrospektif olarak değerlendirmeyi hedefledik. Gereç ve Yöntem: 2016-2019 yılları arası İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi Gastroenteroloji endoskopi ünitesinde perkütan endoskopik gastrostomi kateteri takılmış ve sonrasında perkütan endoskopik gastrostomi kateteri istenmeden çıktığında Foley kateter takılan hastalar gelişen komplikasyonlar ve Foley kateterin kullanım süresi açısından retrospektif olarak değerlendirildi. Bulgular: Çalışmaya verilerine ulaşılabilen 17 hasta dahil edildi. 8 hastada Foley kateterde tıkanma, balonun sönmesi, migrasyona bağlı ileus ve ülser kanaması komplikasyonları gelişti. Komplikasyon gelişmeyen 9/17 hasta grubunda Foley kateter ile takip süresi medyan 6 hafta (1-74 hafta) olarak saptandı. Sonuç: Perkütan endoskopik gastrostomi kateteri yerine Foley kateter kullanımı özellikle yaşam beklentisi çok kısa, endoskopik işlem riski yüksek olan hastalarda uygulanabilecek daha az invaziv, pratik ve ekonomik bir yöntemdir. Ancak hastalar komplikasyonlar açısından yakından takip edilmelidir.
31 December 2020 in Journal of Digestive Endoscopy
Objective In this study, we aimed to investigate the incidence of COVID-19 after endoscopic procedures were performed with elective indications during the normalization process of the COVID-19 pandemic. We also aimed to investigate safety of these procedures. Materials and Methods The study included 351 patients who underwent an endoscopic procedure for elective indications in the endoscopy unit of the gastroenterology department of the İstanbul Kanuni Sultan Süleyman Training and Research Hospital and whose risk assessment for COVID-19 was low before the procedure. All patients were followed-up within 14 days after the procedure in terms of getting a COVID-19 PCR test and its results and also assessing development of any symptoms such as fever, cough, and shortness of breath associated with COVID-19. Results A total of 351 patients were included in the study. A total of 445 procedures were performed: upper gastrointestinal (GI) system endoscopy in 180 patients, colonoscopy in 74 patients, double procedure (upper GI endoscopy + colonoscopy) in 94 patients, and percutaneous endoscopic gastrostomy (PEG) in three patients. It was found that at least one of the symptoms including cough, shortness of breath, and fever developed in 33 (9.4%) of these 351 patients within 14 days. It was observed that 20(5.6‰)of these 33 patients were tested for COVID-19 and the test results were reported as positive in two(5.6‰)patients. Conclusion In the normalization process of COVID-19, elective endoscopic procedures can be performed in patients, who are shown to be low risk, by paying attention to the consummate use of the personal protective equipment (PPE).